Search    |    U.S. | International

PHYSICIANS & HEALTHCARE PROFESSIONALS
Essential Uroplasty Solutions


Urgent® PC
The only outpatient neuromodulation system.


Macroplastique®
Bulking agent for female & male SUI and VUR


MIS
Proven system for non-endoscopic bulking, for use with Macroplastique®


PTQ®
Safe and effective bulking for Faecal Incontinence


VOX®
Safe and effective bulking for Vocal Cord Rehabilitation

 

de la Portilla, F., Fernández, A., León, E., Rada, R., Cisneros, N., Maldonado, V.H., et al. (2008). Evaluation of the use of PTQ™ implants for the treatment of incontinent patients due to internal anal sphincter dysfunction. Colorect Dis, 10(1), 89-94.

OBJECTIVE: This study reports the results of injectable silicone PTQ™ implants for faecal incontinence due to internal anal sphincter (IAS) dysfunction.

METHOD: Twenty patients (12 women) with partial faecal incontinence aged from 55 to 65 years were treated by a PTQ™ implant. All patients completed the Cleveland Clinic Continence and Quality of Life questionnaire. Endoluminal ultrasound and anorectal physiological testing were performed in each patient. All implants were inserted into the submucosal plane without ultrasound guidance.

RESULTS: Faecal continence was significantly improved up to 1 year. The Wexner continence score fell from a median of 13.05 (range, 5-20) before treatment to 4.5 (range 2-7.7) at 1 month after (P < 0.005). This rose gradually to 6.2 (range, 0-16) at one year (P = 0.02) and 9.4 (range, 1-20) at 2 years (P = 0.127). There were no differences in resting or squeeze pressure before and at 3 months after treatment (P = 0.86 and P = 0.93). Fourteen (70%) patients experienced pruritus ani during the first few weeks after the procedure and one developed infection at the implant site.

CONCLUSION: Silicone implantation is minimally invasive and technically simple. It is effective over 1 year in the treatment of faecal incontinence due to IAS dysfunction.

Source: PubMed 17608753

Printer-friendly version (PDF)

<- Back